开放腹主动脉瘤修复术后死亡患者病理事件的深入个体化分析:ACTION-1随机对照试验结果
该研究对ACTION-1随机对照试验中297例开放AAA修复患者进行独立个体化分析,重点评估20例死亡患者。16例(80%)死亡可归因于血栓栓塞或出血事件,其中术中出血是4例的主要死因,术中血栓栓塞是1例的主要死因。多数死亡患者中,围术期出血增加导致低灌注、器官衰竭和休克的病理级联反应。
要点
- 开放AAA修复术后80%死亡可归因于出血或血栓栓塞事件
- 术中出血为主要死因的患者均接受ACT指导的肝素化
- 减少开放AAA修复术后死亡率需针对出血和血栓栓塞并发症
核心结论
- 在297例开放AAA修复患者中,20例死亡患者里16例(80%)死于出血或血栓栓塞事件。
- 多数死亡患者中,围术期出血增加引发低灌注、器官衰竭和休克的病理级联反应。
- 必须处理出血和血栓栓塞并发症以降低择期开放AAA修复术后死亡率。
研究设计与样本
- 对国际随机对照ACTION-1试验中开放AAA修复患者进行独立、详细的个体化分析,共297例。
- 设立裁决委员会评估血栓栓塞或出血事件的可归因性、事件发生于术中或术后、病理事件级联及死亡原因。
- 计算术中出血评分以分层出血严重程度。
主要发现
- 20例死亡患者中,16例(80%)死亡可归因于血栓栓塞或出血事件,4例(20%)死于无关原因。
- 术中出血是4例患者的主要死因,这些患者均接受ACT指导的肝素化。
- 术中血栓栓塞是1例接受5,000 IU肝素患者的主要死因。
临床怎么用
- 开放AAA修复围术期应重视出血和血栓栓塞事件的监测与处理,以降低死亡风险。
- 对接受肝素化患者需平衡出血与血栓风险,ACT指导的肝素化患者中术中出血可为主要死因。
局限性
- 分析仅基于20例死亡患者,样本量小。
- 为随机对照试验的二次分析,结果需进一步验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Elective repair for an abdominal aortic aneurysm (AAA) is performed to prevent rupture and subsequent death. The risk of early mortality is higher after open repair than after endovascular repair and needs to be reduced. Registries lack granular individual data to investigate this increased mortality. An independent, detailed, patient-level analysis of the international randomized controlled ACTION-1 trial was performed to investigate the relation between thromboembolic, hemorrhagic, or other events with mortality after open AAA repair, thereby exploring the cascade of pathological events leading to death. METHODS: An adjudication committee was installed to assess the following domains: attributability of thromboembolic or bleeding event, whether the event occurred intraoperative or postoperative, cascade of pathological events, and cause of death. An intraoperative bleeding score was calculated to stratify the severity of bleeding. RESULTS: In 16 out of 20 deceased patients (80%), death was attributable to a thromboembolic or bleeding event. Four patients (20%) succumbed to causes unrelated to a thromboembolic or bleeding event. Intraoperative bleeding was the primary cause of death in 4 patients, all of whom underwent activated clotting time-guided heparinization. In contrast, an intraoperative thromboembolic event was the primary cause of death in one patient who had received 5,000 IU of heparin. CONCLUSION: In a randomized controlled trial on 297 patients with open AAA repair, 16 out of 20 (80%) deaths were due to bleeding or thromboembolic events. In most deceased patients, increased perioperative bleeding resulted in a pathological cascade of hypoperfusion, organ failure, and shock. Bleeding and thromboembolic complications must be addressed to reduce mortality after elective open AAA repair.
引用
- Steunenberg TAH, Blankensteijn JD, Wiersema AM, et al. In-Depth Patient-Level Analysis of Pathological Events in Patients Not Surviving Open AAA Repair: Results from the ACTION-1 Randomized Controlled Trial. Ann Vasc Surg. 2026. PMID: 41812887. doi:10.1016/j.avsg.2026.02.032
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。